These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9754931)

  • 1. Studies on the teratogen pharmacophore of valproic acid analogues: evidence of interactions at a hydrophobic centre.
    Bojic U; Ehlers K; Ellerbeck U; Bacon CL; O'Driscoll E; O'Connell C; Berezin V; Kawa A; Lepekhin E; Bock E; Regan CM; Nau H
    Eur J Pharmacol; 1998 Aug; 354(2-3):289-99. PubMed ID: 9754931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentyl-4-yn-valproic acid enhances both spatial and avoidance learning, and attenuates age-related NCAM-mediated neuroplastic decline within the rat medial temporal lobe.
    Murphy KJ; Fox GB; Foley AG; Gallagher HC; O'Connell A; Griffin AM; Nau H; Regan CM
    J Neurochem; 2001 Aug; 78(4):704-14. PubMed ID: 11520891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of in vitro anti-proliferative potential with in vivo teratogenicity in a series of valproate analogues.
    Courage-Maguire C; Bacon CL; Nau H; Regan CM
    Int J Dev Neurosci; 1997 Feb; 15(1):37-43. PubMed ID: 9099614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of embryotoxic effects of valproic acid-derivatives with molecular in vitro methods.
    Lampen A; Göttlicher M; Nau H
    ALTEX; 2001; 18(2):123-6. PubMed ID: 11378687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further branching of valproate-related carboxylic acids reduces the teratogenic activity, but not the anticonvulsant effect.
    Bojic U; Elmazar MM; Hauck RS; Nau H
    Chem Res Toxicol; 1996; 9(5):866-70. PubMed ID: 8828922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereoselective dysmorphogenicity of the enantiomers of the valproic acid analogue 2-N-propyl-4-pentynoic acid (4-yn-VPA): cross-species evaluation in whole embryo culture.
    Andrews JE; Ebron-McCoy MT; Bojic U; Nau H; Kavlock RJ
    Teratology; 1997 May; 55(5):314-8. PubMed ID: 9261925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell proliferation, migration and CAM-dependent neurite outgrowth as developmental in vitro endpoints for screening teratogenic potential: Application to valproic acid and related analogues of varying potency.
    Bacon CL; Berezin V; Bode G; Bock E; Bojic U; Doherty P; Ehlers K; Ellerbeck U; Julien P; Kawa A; Maar TE; Nau H; Pirovano R; Regan CM; Schousboe A; Spezia F; Walsh FS; Williams EJ
    Toxicol In Vitro; 1998 Apr; 12(2):101-9. PubMed ID: 20654391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxamic acid and fluorinated derivatives of valproic acid: anticonvulsant activity, neurotoxicity and teratogenicity.
    Gravemann U; Volland J; Nau H
    Neurotoxicol Teratol; 2008; 30(5):390-4. PubMed ID: 18455366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-2-pentyl-4-pentynoic hydroxamic acid and its metabolite s-2-pentyl-4-pentynoic acid in the NMRI-exencephaly-mouse model: pharmacokinetic profiles, teratogenic effects, and histone deacetylase inhibition abilities of further valproic acid hydroxamates and amides.
    Eikel D; Hoffmann K; Zoll K; Lampen A; Nau H
    Drug Metab Dispos; 2006 Apr; 34(4):612-20. PubMed ID: 16415118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproic acid-induced neural tube defects.
    Nau H
    Ciba Found Symp; 1994; 181():144-52; discussion 152-60. PubMed ID: 8005022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential enantioselective effects of pentyl-4-yn-valproate on spatial learning in the rat, and neurite outgrowth and cyclin D3 expression in vitro.
    O'Loinsigh ED; Gherardini LM; Gallagher HC; Foley AG; Murphy KJ; Regan CM
    J Neurochem; 2004 Jan; 88(2):370-9. PubMed ID: 14690525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of peroxisome proliferator-activated receptor delta activity affects neural cell adhesion molecule and polysialyltransferase ST8SiaIV induction by teratogenic valproic acid analogs in F9 cell differentiation.
    Lampen A; Grimaldi PA; Nau H
    Mol Pharmacol; 2005 Jul; 68(1):193-203. PubMed ID: 15829700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell motility is inhibited by the antiepileptic compound, valproic acid and its teratogenic analogues.
    Walmod PS; Foley A; Berezin A; Ellerbeck U; Nau H; Bock E; Berezin V
    Cell Motil Cytoskeleton; 1998; 40(3):220-37. PubMed ID: 9678666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anticonvulsant valproate teratogen restricts the glial cell cycle at a defined point in the mid-G1 phase.
    Martin ML; Regan CM
    Brain Res; 1991 Jul; 554(1-2):223-8. PubMed ID: 1933304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic levels of sodium valproate inhibit mitotic indices in cells of neural origin.
    Regan CM
    Brain Res; 1985 Nov; 347(2):394-8. PubMed ID: 3933765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New molecular bioassays for the estimation of the teratogenic potency of valproic acid derivatives in vitro: activation of the peroxisomal proliferator-activated receptor (PPARdelta).
    Lampen A; Siehler S; Ellerbeck U; Göttlicher M; Nau H
    Toxicol Appl Pharmacol; 1999 Nov; 160(3):238-49. PubMed ID: 10544058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproic acid, but not its non-teratogenic analogue 2-isopropylpentanoic acid, affects proliferation, viability and neuronal differentiation of the human teratocarcinoma cell line NTera-2.
    Skladchikova G; Berezin V; Bock E
    Neurotoxicology; 1998 Jun; 19(3):357-70. PubMed ID: 9621342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of sodium valproate in cultures of human neuroblastoma cells.
    Cinatl J; Cinatl J; Scholz M; Driever PH; Henrich D; Kabickova H; Vogel JU; Doerr HW; Kornhuber B
    Anticancer Drugs; 1996 Sep; 7(7):766-73. PubMed ID: 8949988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of multifactorial genetic liability to exencephaly on the teratogenic effect of valproic acid in mice.
    Hall JL; Harris MJ; Juriloff DM
    Teratology; 1997 May; 55(5):306-13. PubMed ID: 9261924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of differentiation in F9 cells and activation of peroxisome proliferator-activated receptor delta by valproic acid and its teratogenic derivatives.
    Werling U; Siehler S; Litfin M; Nau H; Göttlicher M
    Mol Pharmacol; 2001 May; 59(5):1269-76. PubMed ID: 11306712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.